These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 33736946)

  • 1. Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort.
    Landaas ET; Storm ML; Tollånes MC; Barlinn R; Kran AB; Bragstad K; Christensen A; Andreassen T
    J Clin Virol; 2021 Apr; 137():104789. PubMed ID: 33736946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of RT-PCR and antigen-based rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2 detection: performance, variant specificity, and clinical implications.
    Aboagye FT; Annison L; Hackman HK; Acquah ME; Ashong Y; Owusu-Frimpong I; Egyam BC; Annison S; Osei-Adjei G; Antwi-Baffour S
    Microbiol Spectr; 2024 Jun; 12(6):e0007324. PubMed ID: 38683014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting.
    Osterman A; Baldauf HM; Eletreby M; Wettengel JM; Afridi SQ; Fuchs T; Holzmann E; Maier A; Döring J; Grzimek-Koschewa N; Muenchhoff M; Protzer U; Kaderali L; Keppler OT
    Med Microbiol Immunol; 2021 Feb; 210(1):65-72. PubMed ID: 33452927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time scale performance of rapid antigen testing for SARS-CoV-2: Evaluation of 10 rapid antigen assays.
    Abusrewil Z; Alhudiri IM; Kaal HH; El Meshri SE; Ebrahim FO; Dalyoum T; Efrefer AA; Ibrahim K; Elfghi MB; Abusrewil S; Elzagheid A
    J Med Virol; 2021 Dec; 93(12):6512-6518. PubMed ID: 34241912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern.
    Osterman A; Iglhaut M; Lehner A; Späth P; Stern M; Autenrieth H; Muenchhoff M; Graf A; Krebs S; Blum H; Baiker A; Grzimek-Koschewa N; Protzer U; Kaderali L; Baldauf HM; Keppler OT
    Med Microbiol Immunol; 2021 Dec; 210(5-6):263-275. PubMed ID: 34415422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection.
    Pérez-García F; Romanyk J; Gómez-Herruz P; Arroyo T; Pérez-Tanoira R; Linares M; Pérez Ranz I; Labrador Ballestero A; Moya Gutiérrez H; Ruiz-Álvarez MJ; Cuadros-González J
    J Clin Virol; 2021 Apr; 137():104781. PubMed ID: 33639492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection.
    Jääskeläinen AE; Ahava MJ; Jokela P; Szirovicza L; Pohjala S; Vapalahti O; Lappalainen M; Hepojoki J; Kurkela S
    J Clin Virol; 2021 Apr; 137():104785. PubMed ID: 33711694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres.
    Albert E; Torres I; Bueno F; Huntley D; Molla E; Fernández-Fuentes MÁ; Martínez M; Poujois S; Forqué L; Valdivia A; Solano de la Asunción C; Ferrer J; Colomina J; Navarro D
    Clin Microbiol Infect; 2021 Mar; 27(3):472.e7-472.e10. PubMed ID: 33189872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection-SARS-CoV-2 as a Proof of Concept.
    Rusanen J; Kareinen L; Szirovicza L; Uğurlu H; Levanov L; Jääskeläinen A; Ahava M; Kurkela S; Saksela K; Hedman K; Vapalahti O; Hepojoki J
    mBio; 2021 May; 12(3):. PubMed ID: 34006662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of False-Positive SARS-CoV-2 Antigen Results with Testing Conditions outside Manufacturer Recommendations: A Scientific Approach to Pandemic Misinformation.
    Patriquin G; Davidson RJ; Hatchette TF; Head BM; Mejia E; Becker MG; Meyers A; Sandstrom P; Hatchette J; Block A; Smith N; Ross J; LeBlanc JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0068321. PubMed ID: 34668722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Abbott Panbio
    Shaw JLV; Deslandes V; Smith J; Desjardins M
    Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115514. PubMed ID: 34418823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taqman PACMAN: a simple molecular approach for positive rapid antigen test confirmation during periods of low prevalence.
    McCracken GR; Patriquin G; Hatchette TF; Davidson RJ; Goodall B; Barrett L; MacDonald J; Heinstein C; Pettipas J; Ross J; LeBlanc JJ
    Microbiol Spectr; 2024 May; 12(5):e0407323. PubMed ID: 38567975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak.
    McKay SL; Tobolowsky FA; Moritz ED; Hatfield KM; Bhatnagar A; LaVoie SP; Jackson DA; Lecy KD; Bryant-Genevier J; Campbell D; Freeman B; Gilbert SE; Folster JM; Medrzycki M; Shewmaker PL; Bankamp B; Radford KW; Anderson R; Bowen MD; Negley J; Reddy SC; Jernigan JA; Brown AC; McDonald LC; Kutty PK;
    Ann Intern Med; 2021 Jul; 174(7):945-951. PubMed ID: 33900791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the INDICAID COVID-19 Rapid Antigen Test in Symptomatic Populations and Asymptomatic Community Testing.
    Chiu RYT; Kojima N; Mosley GL; Cheng KK; Pereira DY; Brobeck M; Chan TL; Zee JS; Kittur H; Chung CYT; Tsang E; Maran K; Yung RW; Leung AC; Siu RH; Ng JP; Choi TH; Fung MW; Chan WS; Lam HY; Lee KH; Parkin S; Chao FC; Ho SK; Marshak DR; Ma ES; Klausner JD
    Microbiol Spectr; 2021 Sep; 9(1):e0034221. PubMed ID: 34346748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2.
    Aoki K; Nagasawa T; Ishii Y; Yagi S; Kashiwagi K; Miyazaki T; Tateda K
    J Infect Chemother; 2021 Feb; 27(2):319-322. PubMed ID: 33388232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus.
    Nordgren J; Sharma S; Olsson H; Jämtberg M; Falkeborn T; Svensson L; Hagbom M
    J Clin Virol; 2021 Jul; 140():104846. PubMed ID: 33971580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test.
    Matsuzaki N; Orihara Y; Kodana M; Kitagawa Y; Matsuoka M; Kawamura R; Takeuchi S; Imai K; Tarumoto N; Maesaki S; Maeda T
    J Med Virol; 2021 Dec; 93(12):6778-6781. PubMed ID: 34170555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients.
    Torres I; Poujois S; Albert E; Colomina J; Navarro D
    Clin Microbiol Infect; 2021 Apr; 27(4):636.e1-636.e4. PubMed ID: 33421573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Rapid Antigen Tests for COVID-19.
    Yamayoshi S; Sakai-Tagawa Y; Koga M; Akasaka O; Nakachi I; Koh H; Maeda K; Adachi E; Saito M; Nagai H; Ikeuchi K; Ogura T; Baba R; Fujita K; Fukui T; Ito F; Hattori SI; Yamamoto K; Nakamoto T; Furusawa Y; Yasuhara A; Ujie M; Yamada S; Ito M; Mitsuya H; Omagari N; Yotsuyanagi H; Iwatsuki-Horimoto K; Imai M; Kawaoka Y
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33322035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.